Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 34,762	$ 42,907
Restricted cash	308	308
Marketable securities	189,238	178,075
Trade receivables, net	144,377	146,229
Inventory	37,391	22,634
Prepaid expenses and other current assets	31,980	21,079
Total current assets	438,056	411,232
Property, plant, and equipment, net	1,040	1,043
Intangible assets, net	14,250	14,812
Operating lease right-of-use asset	4,361	4,467
Other assets	2,296	1,419
Total assets	460,003	432,973
Current liabilities:
Accounts payable	18,296	12,528
Current portion of long-term debt, net	7,950	1,000
Accrued and other current liabilities	136,957	116,310
Total current liabilities	163,203	129,838
Operating lease liability, long-term	5,251	5,266
Long-term debt, net	101,470	107,959
Other long-term liabilities	431	431
Total liabilities	270,355	243,494
Commitments and contingencies (Note 7)
Stockholders’ equity:
Common stock, $0.0001 par value; 300,000 shares authorized at March 31, 2026 and December 31, 2025; 125,042 and 123,333 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	12	12
Additional paid-in capital	1,339,529	1,327,595
Accumulated other comprehensive loss	(514)	(44)
Accumulated deficit	(1,149,379)	(1,138,084)
Total stockholders’ equity	189,648	189,479
Total liabilities and stockholders’ equity	$ 460,003	$ 432,973